stockportfolio.pro
Prestige Consumer Healthcare Inc. (PBH)
Healthcare · Drug Manufacturers - Specialty & Generic · NYSE
Prestige Consumer Healthcare Inc. revenue & earnings — last 10 fiscal years
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $882.06M | $1.04B | $975.78M | $963.01M | $943.37M | $1.09B | $1.13B | $1.13B | $1.14B | $1.09B |
| Gross profit | $500.29M | $576.50M | $555.58M | $552.22M | $547.47M | $620.65M | $625.29M | $624.45M | $634.46M | $595.58M |
| Net income | $69.39M | $339.57M | $-35.80M | $142.28M | $164.68M | $205.38M | $-82.31M | $209.34M | $214.60M | $190.30M |
| Net margin | 7.9% | 32.6% | -3.7% | 14.8% | 17.5% | 18.9% | -7.3% | 18.6% | 18.9% | 17.5% |
Source: Prestige Consumer Healthcare Inc. SEC filings (10-K). 17 years of history available in the interactive view.
Explore 17 years of Prestige Consumer Healthcare Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track PBH in your portfolio →
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Prestige Consumer Healthcare Inc. — frequently asked questions
What is Prestige Consumer Healthcare Inc.'s revenue?
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $1.09B for fiscal year 2026, down 4.3% from the prior year, according to its SEC filings.
Is Prestige Consumer Healthcare Inc. profitable?
Yes. PBH earned net income of $190.30M in fiscal 2026, a net margin of 17.5%.
What is PBH's P/E ratio?
Prestige Consumer Healthcare Inc. trades at a price-to-earnings ratio of about 12.6 based on the latest data in our nightly-refreshed cache.
How fast is Prestige Consumer Healthcare Inc. growing?
PBH's revenue grew at roughly 2.9% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Prestige Consumer Healthcare Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.